federal_register: 98-34546

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present.

This data as json

document_number	title	type	abstract	publication_date	pub_year	pub_month	html_url	pdf_url	agency_names	agency_ids	excerpts
98-34546	Financial Disclosure by Clinical Investigators	Rule	The Food and Drug Administration (FDA) is revising the requirements regarding financial disclosure by clinical investigators in order to add material to the codified language that was inadvertently omitted and to clarify the compliance dates to, in some cases, restrict the retroactive application of certain requirements of the rule. FDA is making these changes in order to respond to concerns raised by the Pharmaceutical Research Manufacturers Association (hereinafter referred to as ``PhRMA''). By making these changes, FDA will be reducing the administrative burden for manufacturers and other affected parties while, at the same time, ensuring that the agency obtains the information that is most relevant to its review of clinical data submitted in marketing applications.	1998-12-31	1998	12	https://www.federalregister.gov/documents/1998/12/31/98-34546/financial-disclosure-by-clinical-investigators	https://www.govinfo.gov/content/pkg/FR-1998-12-31/pdf/98-34546.pdf	Health and Human Services Department; Food and Drug Administration	221,199	The Food and Drug Administration (FDA) is revising the requirements regarding financial disclosure by clinical investigators in order to add material to the codified language that was inadvertently omitted and to clarify the compliance dates to, in...

Links from other tables